Skip to main content
. 2021 Oct 21;11:753102. doi: 10.3389/fonc.2021.753102

Figure 3.

Figure 3

Promoter DNA methylation levels of ALDH1A2 (A), OSR2 (B), GATA4 (C), GRIA4 (D), and IRX4 (E) were compared among the patients with different clinical-stages, *P < 0.05.